Literature DB >> 22293536

PharmGKB summary: caffeine pathway.

Caroline F Thorn1, Eleni Aklillu, Ellen M McDonagh, Teri E Klein, Russ B Altman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22293536      PMCID： PMC3381939          DOI： 10.1097/FPC.0b013e3283505d5e

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  42 in total

1.  Association between A2a receptor gene polymorphisms and caffeine-induced anxiety.

Authors:  Karen Alsene; Jürgen Deckert; Philipp Sand; Harriet de Wit
Journal:  Neuropsychopharmacology       Date:  2003-06-25       Impact factor: 7.853

2.  Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1.

Authors:  L Gu; F J Gonzalez; W Kalow; B K Tang
Journal:  Pharmacogenetics       Date:  1992-04

3.  Caffeine metabolism and the risk of spontaneous abortion of normal karyotype fetuses.

Authors:  L B Signorello; A Nordmark; F Granath; W J Blot; J K McLaughlin; G Annerén; S Lundgren; A Ekbom; A Rane; S Cnattingius
Journal:  Obstet Gynecol       Date:  2001-12       Impact factor: 7.661

4.  Spontaneous abortion in a hospital population: are tobacco and coffee intake risk factors?

Authors:  V Domínguez-Rojas; J R de Juanes-Pardo; P Astasio-Arbiza; P Ortega-Molina; E Gordillo-Florencio
Journal:  Eur J Epidemiol       Date:  1994-12       Impact factor: 8.082

Review 5.  The use of caffeine for enzyme assays: a critical appraisal.

Authors:  W Kalow; B K Tang
Journal:  Clin Pharmacol Ther       Date:  1993-05       Impact factor: 6.875

6.  Caffeine intake, CYP1A2 polymorphism and the risk of recurrent pregnancy loss.

Authors:  Fumihiro Sata; Hideto Yamada; Kana Suzuki; Yasuaki Saijo; Emi H Kato; Mamoru Morikawa; Hisanori Minakami; Reiko Kishi
Journal:  Mol Hum Reprod       Date:  2005-04-22       Impact factor: 4.025

7.  Cigarette, alcohol, and caffeine consumption: risk factors for spontaneous abortion.

Authors:  Vibeke Rasch
Journal:  Acta Obstet Gynecol Scand       Date:  2003-02       Impact factor: 3.636

8.  Time response of cytochrome P450 1A2 activity on cessation of heavy smoking.

Authors:  Mirko S Faber; Uwe Fuhr
Journal:  Clin Pharmacol Ther       Date:  2004-08       Impact factor: 6.875

9.  Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1.

Authors:  Eleni Aklillu; Juan Antonio Carrillo; Eyasu Makonnen; Karin Hellman; Marià Pitarque; Leif Bertilsson; Magnus Ingelman-Sundberg
Journal:  Mol Pharmacol       Date:  2003-09       Impact factor: 4.436

Review 10.  A primer on caffeine pharmacology and its drug interactions in clinical psychopharmacology.

Authors:  J L Donovan; C L DeVane
Journal:  Psychopharmacol Bull       Date:  2001
View more
  24 in total

Review 1.  International society of sports nutrition position stand: caffeine and exercise performance.

Authors:  Nanci S Guest; Trisha A VanDusseldorp; Michael T Nelson; Jozo Grgic; Brad J Schoenfeld; Nathaniel D M Jenkins; Shawn M Arent; Jose Antonio; Jeffrey R Stout; Eric T Trexler; Abbie E Smith-Ryan; Erica R Goldstein; Douglas S Kalman; Bill I Campbell
Journal:  J Int Soc Sports Nutr       Date:  2021-01-02       Impact factor: 5.150

2.  Therapy for Apnoea of Prematurity: A Retrospective Study on Effects of Standard Dose and Genetic Variability on Clinical Response to Caffeine Citrate in Chinese Preterm Infants.

Authors:  Xin He; Jin-Chun Qiu; Ke-Yu Lu; Hong-Li Guo; Ling Li; Wei-Wei Jia; Ming-Ming Ni; Yun Liu; Jing Xu; Feng Chen; Rui Cheng
Journal:  Adv Ther       Date:  2020-11-12       Impact factor: 3.845

3.  Serum caffeine concentrations and short-term outcomes in premature infants of ⩽29 weeks of gestation.

Authors:  P Alur; V Bollampalli; T Bell; N Hussain; J Liss
Journal:  J Perinatol       Date:  2014-12-18       Impact factor: 2.521

Review 4.  PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6.

Authors:  Ellen M McDonagh; Catherine Wassenaar; Sean P David; Rachel F Tyndale; Russ B Altman; Michelle Whirl-Carrillo; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-09       Impact factor: 2.089

Review 5.  Candidate Proficiency Test Chemicals to Address Industrial Chemical Applicability Domains for in vitro Human Cytochrome P450 Enzyme Induction.

Authors:  Miriam Naomi Jacobs; Barbara Kubickova; Eugene Boshoff
Journal:  Front Toxicol       Date:  2022-06-20

Review 6.  Neuroprotective Effect of Caffeine in Alzheimer's Disease.

Authors:  Y Mukish M Yelanchezian; Henry J Waldvogel; Richard L M Faull; Andrea Kwakowsky
Journal:  Molecules       Date:  2022-06-10       Impact factor: 4.927

Review 7.  PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2.

Authors:  Ellen M McDonagh; Sotiria Boukouvala; Eleni Aklillu; David W Hein; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-08       Impact factor: 2.089

8.  Expression of Genes for Methylxanthine Pathway-Associated Enzymes Accompanied by Sex Steroid Receptor Status Impacts Breast Carcinoma Progression.

Authors:  James L Wittliff; Seth B Sereff; Michael W Daniels
Journal:  Horm Cancer       Date:  2017-10-02       Impact factor: 3.869

9.  Metabolomic Signatures of Long-term Coffee Consumption and Risk of Type 2 Diabetes in Women.

Authors:  Dong Hang; Oana A Zeleznik; Xiaosheng He; Marta Guasch-Ferre; Xia Jiang; Jun Li; Liming Liang; A Heather Eliassen; Clary B Clish; Andrew T Chan; Zhibin Hu; Hongbing Shen; Kathryn M Wilson; Lorelei A Mucci; Qi Sun; Frank B Hu; Walter C Willett; Edward L Giovannucci; Mingyang Song
Journal:  Diabetes Care       Date:  2020-08-11       Impact factor: 19.112

Review 10.  Influence of Various Factors on Caffeine Content in Coffee Brews.

Authors:  Ewa Olechno; Anna Puścion-Jakubik; Małgorzata Elżbieta Zujko; Katarzyna Socha
Journal:  Foods       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.